Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210

Cancer Res. 1981 Feb;41(2):445-51.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arabinofuranosylcytosine Triphosphate / metabolism
  • Aspartic Acid / administration & dosage
  • Aspartic Acid / analogs & derivatives
  • Cells, Cultured
  • Cytarabine / administration & dosage*
  • Cytarabine / toxicity
  • Cytidine / pharmacology
  • Drug Therapy, Combination
  • Leukemia L1210 / drug therapy*
  • Leukemia L1210 / metabolism
  • Mice
  • Phosphonoacetic Acid / administration & dosage
  • Phosphonoacetic Acid / analogs & derivatives
  • Thymidine / administration & dosage*
  • Thymidine / antagonists & inhibitors

Substances

  • Cytarabine
  • Arabinofuranosylcytosine Triphosphate
  • Aspartic Acid
  • Cytidine
  • sparfosic acid
  • Phosphonoacetic Acid
  • Thymidine